STAT Plus: Novartis to provide drugs for Covid-19 patients at no cost, but fails to disclose pricing
As companies face pressure to ensure access to medicines during the pandemic, Novartis (NVS) plans…
Category: drug pricing
STAT Plus: AbbVie uses dozens of patents to ward off competition for a pricey cancer medicine
The pricey Imbruvica cancer treatment that became available seven years ago could have its monopoly…
STAT Plus: Drug maker offers to slash prices on cancer medicines to end European price gouging probe
In response to a probe into alleged price gouging, Aspen Pharma has agreed to slash…
STAT Plus: Ohio sues Express Scripts for ‘egregiously’ overcharging for medicines
The Ohio Attorney General has filed a lawsuit alleging Express Scripts overcharged a state pension…
STAT Plus: Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: How can cancer drug prices better match their benefits? Germany offers a cost-saving model
A new study finds that after Germany revamped its approach to purchasing medicines a decade…
STAT Plus: Pharmalittle: BioNTech expects to seek approval for vaccine by year-end; why the FDA chose a 50% threshold for Covid-19 vaccines
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Patients should have a role in deciding the value of medicines
Policymakers increasingly consult value assessment models to help price new medical interventions. Value models use…
Despite the pandemic, prices for many drugs keep rising
Despite the economic hardships the Covid-19 pandemic has created for many Americans, drug makers raised…
STAT Plus: Did a pharma trade group try to sabotage a Dutch government report on compulsory licensing?
A Dutch government commission on compulsory licensing was nearly sabotaged last month after one of…
STAT Plus: Johnson & Johnson lowers the price of its TB drug in many poor countries, but is it enough?
After protracted criticism over its pricing for a game-changing tuberculosis medicine, Johnson & Johnson (JNJ)…
STAT Plus: Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges
And so, another working week will soon come to an end. Not a moment too…
STAT Plus: Africa Union urges member countries to remove intellectual property barriers to Covid-19 vaccines
Amid growing concern over access to Covid-19 medical products, the organization that represents dozens of…
STAT Plus: Drug makers sue to block Minnesota law making it cheaper to get insulin in emergencies
WASHINGTON — The drug industry lobbying association PhRMA sued the state of Minnesota over a…
Some U.S. government contracts for Covid-19 research could skirt affordable pricing laws
A new report finds that the U.S. government awarded several drug makers contracts for coronavirus research using…
STAT Plus: Canadian court upholds most of a controversial new rule for controlling excessive drug prices
In a setback to the pharmaceutical industry, a federal court judge in Canada has dismissed…
STAT Plus: After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines
U.K. officials and Vertex Pharmaceuticals (VRTX) have finally put to rest a years-long battle over…
STAT Plus: Gilead’s pricing for remdesivir raises questions about the drug’s long-term prospects
After weeks of anticipation, Gilead Sciences (GILD) finally disclosed the pricing for its remdesivir experimental…
STAT Plus: How Gilead’s remdesivir price could come back to haunt the drug industry
Gilead Sciences, in a self-described effort to do “the right and responsible thing,” may have…
STAT Plus: Pharmalittle: Will a Covid-19 vaccine protect the elderly? Generic remdesivir to cost up to $79 a dose
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Vertex and Canada hold talks over cystic fibrosis drug, but a deal for newer medicine remains out of reach
The icy relationship between Vertex Pharmaceuticals (VRTX) and the Canadian government is showing signs of…
STAT Plus: Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests
For years, the pharmaceutical industry has maintained that the costs to develop medicines accounts for…
STAT Plus: Pharmalittle: Trump pushes for Covid-19 vaccine by year’s end; Americans fear pharma will keep raising drug prices
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT Plus: A majority of Americans fear pharma will use Covid-19 as an excuse to raise prices
Amid a race to find therapies and vaccines to combat Covid-19, a new poll finds…
STAT Plus: Trump administration seeks to encourage ‘value-based’ drug pricing deals with new proposal
WASHINGTON — The Trump administration wants to revamp certain Medicaid rules about drug prices in…
STAT Plus: Pharmalittle: White House says Covid-19 vaccine will be free to the ‘vulnerable’; vaccine makers hunt for glass vials
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Trump administration pledges future Covid-19 vaccines will be free for ‘vulnerable’ Americans
WASHINGTON — The Trump administration on Tuesday pledged to provide a future Covid-19 vaccine for…
.jpg)
STAT Plus: A YouTube ‘hit job’ about a Catalyst Pharma rival is posted amid its battle with the FDA
In a move that resembles a scare tactic, a newly posted YouTube video shows a…
Opinion: Covid-19 and remdesivir: rethinking how we measure a drug’s ‘value’
As pharmaceutical and biotech companies scramble to identify treatments for Covid-19, a new disease that…
STAT Plus: Pharmalittle: Pfizer CEO says Covid-19 vaccine price won’t be huge; Lilly antibody therapy may be ready by fall
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
STAT Plus: States file a third lawsuit accusing dozens of generic drug makers of price fixing
An ongoing probe by numerous states widened with a new lawsuit accusing more than two…
STAT Plus: Wholesale drug prices — and net prices — keep falling for most drugs
Amid continued political pressure on the pharmaceutical industry, a new analysis finds that brand-name drug…
STAT Plus: Pharmalittle: Five Covid-19 vaccine makers chosen for Warp Speed project; Moderna CEO defends data release
Good morning, folks, and how are you today? We are doing just fine, thank you….
STAT Plus: Private insurance might provide some shield from insulin price hikes — but the picture of costs is complicated
Although the cost of insulin has risen dramatically over the years and prompted a political…
STAT Plus: Vertex angers U.K. cystic fibrosis patients with a delay in submitting data for its newest therapy
Vertex Pharmaceuticals (VRTX) has sparked a new round of anger among cystic fibrosis patients in…
Trump tries to convince voters he’s lowered drug prices, based only on a modest tweak to Medicare
WASHINGTON — President Trump used a glitzy Rose Garden address, flanked by pharmaceutical company CEOs…
STAT Plus: Phlow CEO speaks out on criticism of his record, plans for a drug ingredient stockpile, and a huge government contract
Earlier this week, the U.S. government awarded a $354 million contract to a new public…
CEO tapped by Trump to make generic drugs during pandemic has a dicey track record
As the chief executive of Phylo, the new company awarded $354 million by the federal government…
Opinion: Covid-19 has exposed the limits of the pharmaceutical market model
That so much hope is being pinned on remdesivir, the drug Gilead is testing for…
9 ways Covid-19 may forever upend the U.S. health care industry
WASHINGTON — In the U.S. alone, Covid-19 has claimed nearly 100,000 lives and 30 million…
STAT Plus: Despite skepticism, Gilead’s remdesivir could become a ‘multi-year commercial opportunity’
As speculation mounts over pricing for remdesivir, a Gilead Sciences (GILD) executive suggested the experimental…
Opinion: If J&J really wants to support nurses, it should make the TB drug bedaquiline affordable
As nurses who worked in 5B, the first U.S. hospital ward dedicated HIV/AIDS, which opened…
Less than a movie ticket or ‘impossible to overpay’? Experts name their price for remdesivir
Two weeks ago, the world learned that remdesivir, a treatment from Gilead Sciences, has a…
Opinion: Americans think the government should regulate profits from Covid-19 treatments. Be careful what you wish for
As the death toll from the novel coronavirus climbs toward 90,000, a new national survey…
STAT Plus: Pharmalittle: Hydroxycholoroquine fails to help patients in a study; what will states do with the old malaria drug now?
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Maryland governor vetoes funding for a prescription drug affordability board
In a surprise move, Maryland Gov. Larry Hogan vetoed state funding for a “Prescription Drug…
.jpg)
STAT Plus: Apotex to pay $24 million to settle price fixing charges stemming from long-running probe
In the latest fallout from a federal probe into generic drug price fixing, Apotex agreed…
STAT Plus: Orphan drugs improve health — but aren’t priced cost-effectively, study finds
As regulators approve a growing number of orphan drugs, prices for these medicines, which treat small…
Opinion: Exercising Bayh-Dole march-in rights would handicap Covid-19 innovation
Scientists across America are working hard to develop treatments for and vaccines against the novel…
STAT Plus: Pharmalittle: Gilead faces remdesivir production challenges; will scientists run out of Covid-19 trial patients?
And so, another working week will soon draw to a close. Not a moment too…